Weight-Loss Drug MDL In Pa. Grows With 3 New Jersey Cases
By P.J. D'Annunzio · November 13, 2025, 7:04 PM EST
Three New Jersey cases were grouped into multidistrict litigation accusing Eli Lilly & Co. and Novo Nordisk of downplaying alleged side effects of weight loss drugs like Ozempic and Trulicity, according...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login